Company Overview
Bluebird Bio (BLUE) is a biotechnology company developing potentially transformative gene and cell therapies for severe genetic diseases and cancer. Bluebird believes that gene therapy for severe genetic diseases has the potential to change the way patients living with these diseases are treated, by addressing the underlying genetic defect causing the disease, rather than only addressing their symptoms. Bluebird has built an integrated gene therapy platform for various disease indications with their lentiviral-based treatments and gene editing capabilities. In addition, Bluebird has leveraged on their expertise in lentiviral gene delivery and